Crescent Grove Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-53,584
Closed -$2M 280
2024
Q3
$2M Buy
53,584
+1,099
+2% +$39.3K 0.2% 76
2024
Q2
$1.66M Buy
52,485
+37,580
+252% +$1.14M 0.18% 80
2024
Q1
$455K Buy
+14,905
New +$449K 0.05% 192
2023
Q4
Sell
-16,185
Closed -$520K 286
2023
Q3
$520K Buy
16,185
+3,670
+29% +$121K 0.06% 167
2023
Q2
$415K Buy
12,515
+799
+7% +$27.3K 0.04% 192
2023
Q1
$420K Buy
11,716
+1,466
+14% +$55.3K 0.05% 192
2022
Q4
$417K Buy
+10,250
New +$403K 0.04% 196
2022
Q3
Sell
-47,893
Closed -$2.06M 261
2022
Q2
$2.06M Buy
47,893
+9,670
+25% +$415K 0.22% 59
2022
Q1
$1.64M Buy
38,223
+7,603
+25% +$324K 0.16% 72
2021
Q4
$1.17M Buy
30,620
+3,435
+13% +$122K 0.11% 99
2021
Q3
$979K Buy
27,185
+9,175
+51% +$344K 0.1% 103
2021
Q2
$708K Buy
+18,010
New +$705K 0.07% 126

Other funds holding BTI

Crescent Grove Advisors's BTI Position: Q4 2024 in Review

Crescent Grove Advisors sold out of British American Tobacco (BTI) in Q4 2024, closing a stake of 53,584 shares — an estimated $2M sold.

Crescent Grove Advisors first reported a position in BTI in Q2 2021 and held it in 12 quarters. The position peaked at $2.06M in Q2 2022. 620 funds tracked by Wall St. Rank hold BTI as of Q4 2024.

  • Crescent Grove Advisors reported no remaining British American Tobacco position as of Q4 2024 after selling out during the quarter.
  • Crescent Grove Advisors sold 53,584 British American Tobacco shares in Q4 2024, an estimated $2M.
  • Crescent Grove Advisors first reported a position in British American Tobacco in Q2 2021 and held it in 12 quarters.
  • Crescent Grove Advisors's British American Tobacco position peaked at $2.06M in Q2 2022.
  • 620 funds tracked by Wall St. Rank held British American Tobacco as of Q4 2024.

Based on Crescent Grove Advisors's 13F filing for Q4 2024, filed 21 Jan 2025.